Literature DB >> 8334702

T cell activation by clustered tyrosine kinases.

W Kolanus1, C Romeo, B Seed.   

Abstract

Many cellular recognition events in the immune system are initiated by aggregation of cell surface receptors that lack intrinsic protein-tyrosine kinase activity. Receptor-associated kinases related to the src protooncogene product have been found to be essential for cellular activation and may interact with the cytoplasmic domains of the antigen receptor chains. We show here that anti-CD16 antibody-mediated clustering of chimeric transmembrane proteins bearing a CD16 extracellular domain and a Src family kinase intracellular domain is not sufficient to initiate a cellular activation signal in T cells, whereas clustering of similar chimeras bearing Syk or ZAP-70 kinase sequences triggers calcium mobilization. Aggregation of the Syk chimera alone, or coaggregation of chimeras bearing Fyn and ZAP-70 kinases, suffices to initiate cytolytic effector function. The pattern of tyrosine phosphorylation induced by clustering of the Syk chimera is similar to the pattern induced by aggregation of T cell receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334702     DOI: 10.1016/0092-8674(93)90304-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  86 in total

Review 1.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

2.  The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated in pre-T cell receptor signaling.

Authors:  A M Cheng; I Negishi; S J Anderson; A C Chan; J Bolen; D Y Loh; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Cytohesin-1 regulates beta-2 integrin-mediated adhesion through both ARF-GEF function and interaction with LFA-1.

Authors:  C Geiger; W Nagel; T Boehm; Y van Kooyk; C G Figdor; E Kremmer; N Hogg; L Zeitlmann; H Dierks; K S Weber; W Kolanus
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

4.  Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.

Authors:  Sebastian Königsberger; Jan Prodöhl; David Stegner; Vanessa Weis; Martin Andreas; Martin Stehling; Theresa Schumacher; Ruben Böhmer; Ina Thielmann; Judith M M van Eeuwijk; Bernhard Nieswandt; Friedemann Kiefer
Journal:  EMBO J       Date:  2012-06-22       Impact factor: 11.598

5.  Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides.

Authors:  T Kimura; H Sakamoto; E Appella; R P Siraganian
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 6.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

7.  Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  H Lee; J Guo; M Li; J K Choi; M DeMaria; M Rosenzweig; J U Jung
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha.

Authors:  C M Pleiman; C Abrams; L T Gauen; W Bedzyk; J Jongstra; A S Shaw; J C Cambier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Zap70 inhibits Syk-mediated osteoclast function.

Authors:  Wei Zou; Monica Croke; Tomohiro Fukunaga; Thomas J Broekelmann; Robert P Mecham; Steven L Teitelbaum
Journal:  J Cell Biochem       Date:  2013-08       Impact factor: 4.429

10.  Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif.

Authors:  L K Gauen; Y Zhu; F Letourneur; Q Hu; J B Bolen; L A Matis; R D Klausner; A S Shaw
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.